One of the greatest challenges of the post-genomic era is the construction of a more comprehensive human protein interaction map. While this process may take many years to complete, the development of stringent high throughput techniques and the emergence of complementary assays mean that the aim of building a detailed binary map of the human interactome is now a very realistic goal. In particular, methods which facilitate the analysis of large numbers of membrane-protein interactions mean that it will be possible to construct more extensive networks, which in turn provide new insights into the functional connectivity between intra-and extra-cellular processes. This is important as many therapeutic strategies are designed to elicit effects via 'tractable' cell-surface proteins. Therefore, the construction of maps depicting the complexity of trans-cellular communication networks will not only improve our understanding of physiological processes, it will also aid the design of rational therapeutic strategies, with fewer potential side effects. This review aims to provide a basic insight into the approaches currently being used to construct binary human protein interaction networks, with particular reference to newer techniques, which have the potential to extend network coverage and aid the conditional annotation of interactome-scale protein interaction maps.
INTRODUCTION
We now know that the human genome encodes >20 000 proteins, many of which remain uncharacterized. To improve understanding of important physiological and pathological processes, it will be necessary to assemble a detailed binary map which shows how proteins work together to perform a diverse range of complex, yet highly coordinated, processes. This is a formidable challenge. However, progress in recent years has been significant. Building on invaluable pioneering studies performed in model organisms [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] , two large-scale human protein interaction studies [11, 12] have already provided an immense amount of novel data, thereby establishing clear proof of principle for future large-scale human protein interaction studies. As a result, there can be no doubt that the apparently ambitious task of building a binary map of the human interactome is now a realistic goal. However, for this map to be of maximum utility, to both biological and medical research, it must be as comprehensive and dense as possible. Ultimately, we may also expect a high proportion of interactions to be verified using multiple techniques; some of which may provide information relating to the conditional or isoformspecific nature of protein interactions. Clearly, these are long-term, and possibly sequential, targets. However, it is interesting to consider how each of these goals may be achieved; what technical developments have made 'high-coverage' human protein interaction maps a realistic possibility; and what challenges still remain to be overcome.
STEP 1: GENERATING A DRAFT FRAMEWORK
Logically, the first phase of map building must be the construction of a draft, binary network. Although incomplete, a draft network will provide a vital contextual framework, which can then be extended and refined, either by analysing more proteins or by using alternate techniques, which provide complementary information. In principle there are two ways in which a primary network could be assembled: either by working outwards from known areas of interest, or by following a functionally unbiased strategy in which all proteins are systematically analysed in no specific order. There are good reasons why the latter approach may be the fastest and most productive way to drive the construction of a global human protein interaction map.
This can be explained using a simple analogy: when explorers were building early charts of the globe, they had no choice but to work outwards from where they lived. Not surprisingly, early maps (pre-1500 AD) show very detailed coverage of Europe, but inaccurate and incomplete coverage of more peripheral areas of the map. Clearly, this process of 'mapping by expansion' did eventually work. However, the task would have been infinitely easier, if, instead of starting with a detailed local map, explorers had been given an incomplete chart showing the partial outlines of most countries or continents, presented in reasonably accurate spatial context. Not only would explorers have had a better idea of where they should be heading, they would also have been able to focus efforts on filling in the obvious gaps. In addition, it would have been possible to place existing 'local maps' into a more meaningful global context.
Exactly the same principles apply to the construction of an interactome-scale human protein interaction map. However, unlike global explorers, we are in the fortunate position of knowing exactly what should be in the final map. Thanks to the invaluable efforts of the Mammalian Gene Collection (MGC) (mgc.nci.nih.gov) and the Human Orfeome Project (horfdb.dfci.harvard.edu), it is possible to perform the kind of large-scale unbiased screens, which are required to generate an interactome-wide draft network. Although this network will certainly be incomplete, it will nevertheless provide the vital information required to expedite future phases of construction and refinement. More importantly, data generated by this approach will be equally valuable to all areas of biological and medical research.
Despite the obvious logic behind the construction of an unbiased draft network, this does not mean that smaller-scale biologically focused projects are now redundant. Although a functionally unbiased draft network will expedite the process of map building, it will not (at least for several years) provide complete coverage of all interactions or biological processes. Therefore, at present there is still a need for complementary focused studies, which provide more detailed 'high-resolution' insights into regions of the interactome, which relate to biological processes or proteins that are directly relevant to ongoing medical research. In the instances where these kinds of biologically-focused maps have been constructed, results show that local network coverage is significantly increased [13] [14] [15] [16] [17] , thereby promoting more productive hypothesis driven research. For this reason it is essential that all data from small-scale biologically focused projects is routinely submitted to curated IMEx (The International Molecular Exchange Consortium) associated databases such as: IntAct, DIP, MINT or BioGrid (see Table 3 for details). This information will significantly enhance network coverage, thereby increasing the utility of evolving human protein interaction networks.
EXTENDING THE BOUNDARIES OF HUMAN PINs
To date, construction of large-scale protein interaction maps has been driven by two main technologies: the yeast two-hybrid system [18] which detects 'binary' or direct protein interactions; and combined affinity purification/mass-spectrometry methods [3-5, 19, 20] , which reveal the composition of protein complexes. Clearly, these are highly complementary techniques, which continue to provide massive amounts of valuable data. Although both techniques can detect some membrane-protein interactions (MPIs), neither is ideal for this purpose. As 20-30% of human genes encode membrane proteins [21] [22] [23] , the lack of data relating to these proteins seriously undermines the utility of existing human protein interaction networks. Fortunately, alternative methods have now been developed to study both intracellular and extracellular MPIs.
With respect to intracellular MPIs, there is now a range of variant two-hybrid methods which can be used to analyse these interactions in either yeast or mammalian cells [24] . Assays that can be used in yeast include: the Ras-based SOS assay [25, 26] , the G-protein based Y2H system [27] , two variations of the split-ubiquitin assay [28, 29] , and most recently a yeast adapted version of the dyhydofolate-reductase (DHFR) split-component cell-survival assay [30] . In addition, techniques such as fluorescence energy transfer (FRET) [31] , the b-galactosidase complementation assay [32] , and the split b-lactamase PCA [33] have all been used to investigate MPIs in mammalian cells. Although each of these techniques have been successfully used in small-scale studies, only two have been developed into high throughput (HTP) formats capable of investigating large numbers of intracellular MPIs.
The transcription-based split-ubiquitin assay, or Membrane Yeast Two Hybrid (MYTH) system [29] , has proved to be a very powerful and robust method of analysing interactions between proteins within the same membrane, or between membrane and cytoplasmic proteins ( Figure 1A ) [34] . As such, this assay provides an excellent opportunity to extend human protein interaction maps outwards to the periphery of the cell.
In addition to the major contributions being made by the MYTH system, there have also been important developments in the use of protein fragment complementation assays (PCAs) to investigate intracellular protein interactions on a global scale. Using a yeast-adapted DHFR PCA system ( Figure 1B) , Tarassov et al. [30] recently produced an alternate binary map of the yeast interactome. In this study the authors used a collection of 4326 DHFR F(1,2) 'Bait' proteins and 4804 DHFR F(3) 'Prey' proteins to perform >15 million array based PCAs. After filtering, 2770 high-confidence positive interactions were detected, involving 1124 different proteins. Interestingly, many MPIs were also detected in this study. In addition, 80% of the high confidence interactions reported by Tarassov et al. (2008) were not detected in previous global yeast two-hybrid [6, 9] or co-complex [3, 5] based yeast interactome mapping studies. Therefore, it would appear that HTP PCA methods may provide valuable complementary data relating to a broad range of functionally diverse intracellular protein interactions.
As both the MYTH system and the yeast adapted DHFR PCA method can be used in HTP format, there is now a real potential to use these assays to perform large-scale systematic studies of human protein interactions. While these methods will increase coverage of existing human protein interaction networks, the formidable challenge of exploring extracellular protein interactions (EPIs) will require different specialized techniques.
EXPLORING EPI NETWORKS
In vivo cells exist in a complex and variable environment. Communication between intracellular and extracellular compartments is dependent upon a diverse range of protein interactions, which include: the clustering of cell surface receptors, receptorligand interactions, cell-cell recognition events and selective cell-matrix interactions. Given the diversity of these functions, it is not surprising that EPIs play a vital role in many developmental, physiological and pathological processes. However, despite their importance, EPIs are dramatically under-represented in all protein interaction networks. This lack of information is not surprising as EPIs tend to have both low affinities (10-100 mM) and fast dissociation rates [35, 36] . As a result, many EPIs cannot be analysed by conventional biochemical methods. To complicate matters further, they may also be dependent on conformations or post-translational modifications, which are only acquired during exocytic transport. To overcome these problems, experimental systems have been developed which enable extracellular proteins (or domains) to be expressed in human cells in a form that facilitates their assembly into multimeric complexes [37] [38] [39] [40] 42] . This process enhances avidity, thereby increasing the probability of detecting even extremely weak binary interactions.
As for all HTP systems, proof of principle was initially established by a series of pioneering smallscale studies [35] [36] [37] [38] [39] [40] . However, translating these principles into a robust HTP format was a significant challenge. Interestingly, two different methods of analysing large numbers of EPIs have now been developed.
The 'Wright' way to investigate EPIs
The AVEXIS (AViditiy-based EXtracellular Interaction Screen) system [22] (Figure 1C ) is an important contribution to Network Biology as it provides a stringent method of analysing large numbers of targeted binary EPIs; including interactions that have extremely short half-lives (<0.1 s). In the MYTH system bait proteins (either integral or membrane-associated proteins) are fused to the C-terminal half of ubiquitin (CUB) and a transcription factor (TF). Prey proteins, which can be either membrane or cytosolic proteins (CytoPrey), are expressed as fusions with the N-terminal half of ubiquitin (NUB). Interaction between bait and prey proteins results in reconstitution of ubiquitin, which is then cleaved by a USB protease, thereby releasing the transcription factor, which then travels to the nucleus and turns on expression of a reporter gene. (B) In the yeast split DHFR assay bait proteins are fused to DHFR fragment (1, 2), while prey proteins are fused to DHFR fragment (3). Interaction of bait and prey proteins results in reconstitution of a correctly folded DHFR enzyme. In this assay cells containing a reconstituted active DHFR enzyme will survive and grow under selective conditions. (C) The AVEXIS system is an ELISA style assay used to detect EPIs. In this assay bait and prey proteins are generated in human cells. Bait proteins are bioinylated to facilitate orientated binding to streptavidin-coated plates. Adsorbed bait proteins are then probed with pentameric prey complexes in which the ectodomain of a prey protein is fused to the pentamerization domain of COMP and the b-lactamase enzyme to facilitate colorimetric detection of bound protein complexes. (D) In the Dscam assay, receptor (bait) proteins are fused to the human placental alkaline phosphatase protein (AP), while ligand (prey) proteins are fused to the FC region of the human IgG1 protein. Receptor and ligand constructs are incubated together with culture media containing horse radish peroxidise (HRP) conjugated a-IgG in plates pre-coated with antibodies against AP. After repeated wash cycles, a colorimetric reporter system is used to assess the extent of protein interaction by measuring bound HRP activity.
In brief, AVEXIS is an ELISA style assay in which the ectodomains of membrane proteins are expressed as biotinylated baits in order to facilitate oriented binding to streptavidin-coated plates. Bait proteins are then probed with soluble pentameric prey complexes containing the b-lactamase protein to facilitate detection of bait-prey interactions. To date the AVEXIS assay is the only HTP method which has been used to explore interactions occurring between a range of different extracellular proteins. However, a second very effective assay system has also been developed to investigate the staggeringly complex combinatorial interactions that occur between isoforms of the Drosophila Dscam protein.
The Dscam EPI assay system
As with the AVEXIS system the Dscam assay ( Figure 1D ) is an ELISA-based method, which uses multimerized bait and prey constructs to enhance avidity [41] . However, in the Dscam system, 'receptor' (bait) proteins are fused to the placental alkaline phosphatase protein while 'ligand' (prey) proteins are fused to the FC region of the human IgG1 protein. While the DSCAM assay was developed to investigate interactions between Drosophila proteins, it is reasonable to presume that the same principle could be successfully applied to human EPIs.
In theory, systems such as the SAC (Selection by Avidity Capture) phage display system [43] could also be used to identify novel EPIs. However, it may be hard to achieve the level of throughput demonstrated by the AVEXIS or Dscam assay systems. In addition, conformation and/or post-translational modifications would not be reproduced in a bacterial system. Finally, as many EPIs may be mediated by multiple contact points, the strength of individual peptide interactions may be very low [44] . Therefore, given the availability of human Orfeome clones, it would appear that HTP targeted pair wise interaction screens may offer the most productive strategy for constructing high coverage maps of human EPIs.
Given that there is now a range of complementary HTP techniques, which can be used to construct binary protein interaction maps, covering both 'intra-' and extra-cellular regions (Figure 2 ), the next challenge is to increase network coverage and enhance confidence in existing unverified protein interaction data. Although the classical yeast two-hybrid method (A) can detect some MPIs, the main contribution of this technique is to provide primary coverage of a broad range of intracellular protein interactions. Alternative assays such as the mammalian cell based MAPPITassay (B) also provide information relating to intracellular protein interactions. While both techniques are used to explore intracellular interactions, coverage will most likely be complementary, as both assays will detect both common and unique interactions. Protein complementation and split component (PCA/SC) assays can provide coverage of all types of intracellular protein interactions including those involving membrane proteins (C). The MYTH assay (D) is specifically designed to investigate integral or membrane associated proteins. The AVEXIS and Dscam assays (E) can be used to investigate a range of EPIs. By integrating data from all of these assays (F), it is possible to provide maximum network coverage, generating maps which link intracellular and EPI networks. In combined networks the overlap between different datasets not only maximizes coverage but also allows increasing confidence values to be annotated for interactions detected in multiple assays (darker grey areas).The different types of protein interactions detected in different assays are shown in black.
Cartographers toolbox'VERIFYING' INTERACTIONS AND INCREASING NETWORK COVERAGE
It is logical to think of the process of map building in sequential phases: construction of a draft network; verification of primary data; and finally, functional or conditional annotation of interactions. However, in practice, the boundaries between these processes are blurred. If HTP Y2H methods are used to construct the primary network, then there is a selection of complementary assays that can be used to reanalyse primary data or provide an independent series of interaction profiles ( Table 1) . As different assay systems tend to produce overlapping but distinct interaction profiles [30, 45] , secondary assays can also provide valuable new data, which increases coverage of the primary network ( Figure 2) . As no single protein interaction assay can be used to categorically prove, or disprove, Y2H data, 'verification' must be achieved by a system of increasing confidence, where interactions detected by independent techniques are assigned increasing confidence scores. Given that all primary interactions are not normally retested in multiple assays and that no single assay can detect all possible interactions, it has been proposed that there may be real value in constructing human protein interaction maps from stringently controlled primary data from multiple independent systems [46] . Although the construction of maps from 'unverified' data may seem contentious, it is reasonable to presume that integration of high quality primary data from independent assays (or projects) may be a rational, and cost effective, way of assembling higher confidence human interaction networks. To facilitate this process, strategies are now being developed to facilitate the empirical annotation of both experimentally defined and projected confidence levels for all human protein interactions. Given the important role that secondary assays will play in map construction, it is pertinent to discuss the range of assays that are now available and the types of data that they may provide.
WHAT TOOLS ARE IN THE TOOLBOX?
Four complementary assays, which could be used to generate a draft binary network including both intracellular and extracellular interactions are: the classical Y2H system, the MYTH assay, the AVEXIS Both proteins are co-expressed in human cells prior to lysis and co-precipitation with anti-myc antisera. This has proved to be a very effective method of verifying primary Y2H data. However, throughput may not be as high as systems listed above.
[11]
MAPPIT Mammalian cells A variant two-hybrid system based on the JAK kinase signalling system. Uses a luciferase transcriptional reporter to monitor interaction between bait and prey proteins. Provides broad coverage of non-membrane intracellular protein interactions.
[ 45, 48] LUMIER Mammalian cells A sensitive co-precipitation assay in which one protein is fused to luciferase and the second to the FLAG-tag. Proteins are co-expressed in mammalian cells prior tAo precipitation with anti FLAG-tag antibodies. Lucifierace activity is then assayed to asses bait/prey interaction. Provides broad coverage of intracellular protein interactions.
[56]
NAPPA

In vitro
The 'Nucleic acid programmable protein array' method. Bait proteins are expressed as GST fusions while prey proteins are fused to the HA-tag. Proteins are co-expressed in vitro. The amount of protein generated in this assay system may be limiting for some low affinity interactions or proteins with fast on off rates. Theoretically this assay could provide wide coverage of interactions between soluble intracellular proteins.
[ 51, 52] Split component/ PCAs
Mammalian, yeast or bacterial cells
There are now a diverse range of split component/PCA systems, which can be used to investigate binary protein interactions in a range of cell types. Initial data suggests that data from these methods may be complementary to Y2H data. Therefore, the true utility of these approaches may be in increasing network coverage, rather then verification of existing data from other assays. [53] system and the yeast adapted DHFR PCA method ( Table 2) . As the DHFR PCA method can be used to study a broad range of intracellular protein interactions (including MPIs), it is highly likely that this approach will provide complementary coverage of protein interactions detected in either classical Y2H or MYTH-based studies. In addition, there is also a variant version of the MYTH assay, which can be used to study non-membrane-related intracellular protein interactions [47] . Both the cyto-MYTH method and the yeast adapted split DHFR assay may provide useful ways of analysing proteins which are inherently problematic in the classical Y2H system. Other assays which may provide secondary or alternative coverage of human protein interaction networks include: the MAPPIT [45, 48] and TEV [49] variant two-hybrid systems [50] , the in vitro NAPPA assay [51, 52] , and a collection of PCA methods, many of which can be performed in mammalian cells [53] . In essence, PCAs can be divided into two groups, based on the reversibility of the reaction. While some enzymatic PCAs are reversible [53, 54] , those based on the reconstitution of fluorescent proteins are not [55] . As such, splitfluorophore assays essentially function as interaction 'traps', locking bait and prey proteins in a permanent complex. In theory, this method could provide a useful way of capturing very transient interactions. However, capture of non-specific interaction partners can be a problem in this system [55] . Although parallel screening with interaction defective mutants can eliminate this problem, this requirement clearly limits both the utility and throughput of this approach.
More conventional secondary assays include the co-precipitation of partners following co-expression of GST or epitope-tagged partners in human cells [11] . The LUMIER system [56] offers a more sensitive, semi quantitative version of the standard co-precipitation method. In this assay one protein is fused to the FLAG-tag while a second is fused to luciferase. Following precipitation with anti FLAGtag antibodies, luciferase activity is measured to determine the degree of bait prey interaction.
Given the broad spectrum of binary protein interaction assays that now exist, it should be possible to reanalyse interactions in multiple systems. However, it is important to remember that the majority of assay systems still involve the over expression of potential interaction partners. Therefore, as protein interactions are dependent upon both relative affinity and protein concentration, there may still be a significant difference between our ability to reconfirm protein interactions in multiple assays and the true physiological relevance of each interaction. At present the process of reconfirmation still represents a major bottle neck in the process of map construction. This is particularly true for EPIs. Due to the inherent problems of identifying EPIs, there is no equivalent range of independent assays which can be used to confirm or re-screen these interactions. As such, relatively low throughput biophysical methods are conventionally used to measure the dissociation rates of putative partners [22, 36] . In this respect [29]
Split-DHFR Yeast A pioneering HTP assay has been performed with this system. Overall coverage may be lower then the Y2H technique, however, this assay provides large amounts of novel data involving proteins of many different functional classes, including integral and membrane associated proteins. As such, this assay may prove to be a valuable complementary HTP primary binary interaction assay.
[30]
AVEXIS
In vitro Proteinsare produced in human cells
This high stringency assay can be used in HTP to detect interactions between the extracellular domains of cell surface proteins and ligand/receptor interactions. This is the only assay to date that can be used in current format to study large numbers of human extracellular protein interactions. [22] Cartographers toolboxthroughput may be improved by the emergence of new biosensor arrays which permit up to 36 interactions to be measured in parallel [57] .
OUTLOOK
Recent years have seen outstanding contributions to the field of Human Network Biology. Large-scale Y2H [11, 12] screens and complementary mass spectrometry studies [19, 20] have gone far beyond proof of principle, providing a wealth of novel information and a firm foundation for future phases of map construction. Add to these achievements the emergence of complementary techniques, which provide an opportunity to investigate large-numbers of intracellular and extracellular MPIs, and there should be no doubt that the goal of constructing an informative draft of the human interactome is now a realistic possibility. However, while these techniques provide the tools required to build human protein interaction networks, the process of map building is still at a very early stage. Despite the impressive contributions made by two large-scale yeast twohybrid studies [11, 12] , plus the combined data from thousands of small-scale studies, current coverage of the human interactome is estimated to be around 8-10% [45, 46] including 50 000-57 000 binary interactions [58] . Extrapolation of existing data has led to predictions that the completed human interactome may contain as many as 375 000 [59] or 74 000-200 000 [45] binary protein interactions. These figures raise several important issues. The existing low coverage impairs meaningful interpretation of both local and global network topology [60, 61] . As such, many physiologically important network features may not yet be apparent. In addition, the potential for functional redundancy or antagonism within the human interactome cannot be accurately determined. However, computational methods which integrate protein interaction data from multiple species [62, 63] provide an important method of increasing the coverage and functional annotation of human protein interaction networks. Even at this early stage, it is clear that available data is providing a valuable resource for both 'systems level' and small-scale research projects. Clearly the utility of human protein interaction networks will only increase as data from future studies is incorporated into the evolving map. In order for this information to be of maximal utility it must be stored in curated databases, which provide user friendly interfaces that facilitate the visualisation, comparison and interrogation of large evolving datasets (see Table 3 for examples). Not surprisingly, the increasing complexity of human protein interaction networks also presents a formidable challenge. Our perception of ordered physiological pathways and linear signalling cascades are already being seriously challenged. Even at this early stage of map construction, it is becoming obvious that components of classical 'pathways' are seamlessly embedded into a complex interconnected network. Therefore, one of the major challenges in the field of Network Biology will be to define the functional boundaries of different biological pathways or processes. This will require a far better understanding of the conditional nature of protein interactions, and the effects that changes in protein interaction profiles may have on network topology. Some promising results have already been obtained using reversible in vivo PCA systems, which have been used to define conditional variations in protein interaction profiles [54, 64] . By combining these methods with targeted RNAi screens, it may be possible to provide new insights into the important question of how specific processes are regulated within the context of complex networks.
In conclusion, it is clear that we are now in a very exciting period of scientific exploration. However, if we are to develop a better understanding of important physiological processes, we will certainly need to be committed to the construction of a bigger and better human protein interaction map.
